Nicholas P. Restifo | |
|---|---|
| Born | 24 July 1960 |
| Nationality | American |
| Education | Johns Hopkins University, New York University School of Medicine |
| Occupation | Immunologist |
| Known for | T cell-based immunotherapy |
Nicholas P. Restifo (born July 24, 1960) is an American immunologist, physician and educator in cancer immunotherapy. Until July 2019, he was a tenured senior investigator in the intramural National Cancer Institute of the National Institutes of Health at Bethesda, Maryland.[1][self-published source?] Nicholas was an executive vice president of research at Lyell based in San Francisco.
Restifo has been a pioneer in the use of T cell-based immunotherapy.